BioBasics: Toronto, Canada

Stacey Franklin

Date: May 31, 2017
Time: 9:00 am  to  4:30 pm

BioBasics: Biotech for Non-Scientists

DateMay 31-June 1, 2017
Time9:00 am – 4:30 pm
Fee$995 USD
LocationMaRS Centre, South Tower, 101 College Street, Conference Room CR-2, Toronto, Ontario, Canada M5G 1L7
ExtrasLunch and all course materials included
BioBasics: Biotech for Non-Scientists

BioBasics™ is an intensive course starting with a review of scientific concepts required for understanding the biopharma industry. Building on this knowledge, the course delves into the cause of disease, the drug discovery process used to identify therapeutics, and the biomanufacturing standards followed to produce therapeutics. Day two begins with an explanation of how the body fights disease and how various medicines work, on the molecular level, to aid the body back to health. The latest innovations in vaccines, monoclonal antibodies, stem cells, immunotherapies, inhibitors, CART, exon-skipping, RNA therapies and much, much more are discussed in enough detail to help you be dangerous.

Biotech Primer delivers current, industry relevant training for biotech industry professionals. Not a scientist? Not a problem!  Our industry expert instructors explain the science and technology used in the lab in a concise, easy to follow manner.

Questions?

About this course?
Our customized in-house options?

All registrants will receive a complimentary copy of our book, The Biotech Primer, at the event.
Register Today!
Register
In partnership with
Location

MaRS Centre, South Tower
101 College St
Toronto, Ontario, Canada M5G 1L7

Agenda

Day One
Biology: The Basis of Biotech 9:00-10:15
Biotechnology Defined
Healthcare Biotech Overview
Biotechnology Goals
Cell Structure & Function
Proteins: Critical to Cellular Function
Cellular Communication: Cell Signaling Pathways
Lab: DNA Isolation & Extraction

Break 10:15- 10:30

DNA: Biotech’s Blueprint 10:30-11:30
DNA Structure & Function
Chromosomes & Genes
How DNA Codes for Proteins
Protein Structure & Function
The Proteome

Genetic Variation 11:30-12:30
Alleles
Mutations: Source of Genetic Variation
Epigenetics
Genetic Basis of Disease
Stratified Medicine
Companion Diagnostics
Activity: Genetic Variation Taste Test

Lunch provided 12:30-1:30

Making Biologics 1:30-2:45
Recombinant DNA
Polymerase Chain Reaction (PCR)
Production Platforms: Bacterial Cells, Mammalian Cells
Production Platforms: Pharm Animals, Pharm Plants
Fusion Protein Therapeutics
Biosimilars

Break 2:45-3:00

Biomanufacturing 3:00-4:15
Cell Line Development & Cell Banking
Scale-Up, Harvest & Purification
Harvest & Purification
Formulation, Fill & Finish
Activity: Column Chromatography

Q&A|Review 4:15-4:30

 

Day Two
Immune System Overview & Introduction to Antibodies 9:00-10:15
Cells of the Immune System
Non-Specific Immune Response: Inflammation
Specific Immune Response: T-Cells & B-Cells
Antibodies: Structure & Function
Immunological Memory
How Vaccines Work
Advances in Vaccine Technology: DNA Vaccines

Break 10:15-10:30

Antibodies as Therapeutics 10:30-11:30
Polyclonal vs. Monoclonal Antibodies
Making Therapeutic Antibodies: Hybridomas, Genetically Engineered Mice
Humanized vs. Fully Human Antibodies
Antibody Constructs: Bispecific & Trispecific Antibodies
Monoclonal Antibodies as Therapeutics: Mechanism of Action
Monoclonal Antibodies in Infectious Disease: RSV, Ebola
Antibody-Drug Conjugates

Checkpoint Inhibitor Therapies

Genomics 11:30-12:30
Genomics Defined
Non-Coding DNA: The Regulome
DNA Microarrays (Gene Chips)
Next Generation Sequencing
Applications of Next Generation Sequencing
Personalized Medicine: Integrating the “‘Omics”
From Big Data to Rare Disease
Third Generation Sequencing
Activity: Microarray to Determine Drug Metabolism

Lunch provided 12:30-1:30

Controlling Gene Expression 1:30-2:30
RNA Therapeutics: Antisense, siRNA, microRNA
Changing Gene Expression: Exon-Skipping Therapy
Gene Therapy
Genome Editing Therapy: Zinc Finger Nucleases, CRISPR/Cas9

Break 2:30-2:45

Stem Cells & Regenerative Medicine 2:45-3:30
Properties of Stem Cells
Promises & Challenges
Induced Pluripotent Stem Cells
Stem Cells in the Clinic

Newly Approved & In Development 3:30-4:15
Living Drugs: Chimeric Antigen Receptor Therapies (CART)
Viral Cancer Vaccine
Curing Hepatitis C
Liquid Biopsies
Exosome-Based Therapeutics

Q&A|Review 4:15-4:30

All course materials are handed out at the course. There is no pre-work required. Lunch will be provided.

Instructor

Kevin Curran, PhD

Dr. Curran received his B.S. in Biology from Southern Oregon University and his Ph.D in Developmental Genetics from the University of Washington in Seattle. Prior to joining Biotech Primer, Dr. Curran worked in the field of cancer research at Memorial Sloan Kettering Cancer Center, where he analyzed the effect of small molecule therapies on apoptosis, or programmed cell death. Dr. Curran then worked in the stem cell field at UCSF, helping design procedures to generate replacement heart tissue for mammals. Most recently, he has worked in the field of behavioral neuroscience at the Salk Institute, exploring the manner that serotonin modulates various human behaviors, such as phobias and anxiety. He is currently teaching cell biology at the University of San Diego.

Refund Policy

All Purchases are in US Dollars. All courses and products are final sale. No refunds, exchanges or transfers.  If you cannot attend your purchased event, you may send someone in your place by notifying Sheila Wagner, Wagner@BiotechPrimer.com, no later than one week before the start date of the class. With the purchase of this course, you will automatically be registered for our WEEKLY. You will receive this free educational newsletter, conveying the science behind the headlines, every Thursday. You may unsubscribe with one click at anytime.

Learn More